Brown M - Search Results

1

Patient and physician perceptions of treatment of moderate-to-severe chronic pain with oral opioids.

Duensing L, Eksterowicz N, Macario A, Brown M, Stern L, Ogbonnaya A. Duensing L, et al. Among authors: brown m. Curr Med Res Opin. 2010 Jul;26(7):1579-85. doi: 10.1185/03007991003783747. Curr Med Res Opin. 2010. PMID: 20429822

2

A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty.

Viscusi ER, Gimbel JS, Halder AM, Snabes M, Brown MT, Verburg KM. Viscusi ER, et al. Among authors: brown mt. Anesth Analg. 2008 Aug;107(2):652-60. doi: 10.1213/ane.0b013e31817e66d4. Anesth Analg. 2008. PMID: 18633048 Clinical Trial.

3

Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.

Kudrow D, Thomas HM, Ruoff G, Ishkanian G, Sands G, Le VH, Brown MT. Kudrow D, et al. Headache. 2005 Oct;45(9):1151-62. doi: 10.1111/j.1526-4610.2005.00238.x. Headache. 2005. PMID: 16178945 Clinical Trial.

4

Tanezumab for the treatment of pain from osteoarthritis of the knee.

Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, Brown MT. Lane NE, et al. Among authors: brown mt. N Engl J Med. 2010 Oct 14;363(16):1521-31. doi: 10.1056/NEJMoa0901510. Epub 2010 Sep 29. N Engl J Med. 2010. PMID: 20942668 Free PMC article. Clinical Trial.

5

Efficacy and safety of tanezumab in the treatment of chronic low back pain.

Katz N, Borenstein DG, Birbara C, Bramson C, Nemeth MA, Smith MD, Brown MT. Katz N, et al. Pain. 2011 Oct;152(10):2248-2258. doi: 10.1016/j.pain.2011.05.003. Epub 2011 Jun 21. Pain. 2011. PMID: 21696889 Clinical Trial.

6

Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis.

Shinde M, Rodriguez-Watson C, Zhang TC, Carrell DS, Mendelsohn AB, Nam YH, Carruth A, Petronis KR, McMahill-Walraven CN, Jamal-Allial A, Nair V, Pawloski PA, Hickman A, Brown MT, Francis J, Hornbuckle K, Brown JS, Mo J. Shinde M, et al. Among authors: brown js, brown mt. BMC Musculoskelet Disord. 2022 Sep 23;23(1):883. doi: 10.1186/s12891-022-05823-7. BMC Musculoskelet Disord. 2022. PMID: 36151530 Free PMC article.

7

Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain.

Gimbel JS, Kivitz AJ, Bramson C, Nemeth MA, Keller DS, Brown MT, West CR, Verburg KM. Gimbel JS, et al. Among authors: brown mt. Pain. 2014 Sep;155(9):1793-1801. doi: 10.1016/j.pain.2014.06.004. Epub 2014 Jun 14. Pain. 2014. PMID: 24937440 Clinical Trial.

8

Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain.

Schnitzer TJ, Lane NE, Birbara C, Smith MD, Simpson SL, Brown MT. Schnitzer TJ, et al. Among authors: brown mt. Osteoarthritis Cartilage. 2011 Jun;19(6):639-46. doi: 10.1016/j.joca.2011.01.009. Epub 2011 Jan 18. Osteoarthritis Cartilage. 2011. PMID: 21251985 Free article. Clinical Trial.

9

Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.

Konno SI, Nikaido T, Markman JD, Ohta M, Machida T, Isogawa N, Yoshimatsu H, Viktrup L, Brown MT, West CR, Verburg KM. Konno SI, et al. Among authors: brown mt. Pain Manag. 2022 Apr;12(3):323-335. doi: 10.2217/pmt-2021-0040. Epub 2021 Nov 17. Pain Manag. 2022. PMID: 34786956 Free article. Clinical Trial.

10

Development of pain therapies targeting nerve growth factor signal transduction and the strategies used to resolve safety issues.

Bélanger P, West CR, Brown MT. Bélanger P, et al. J Toxicol Sci. 2018;43(1):1-10. doi: 10.2131/jts.43.1. J Toxicol Sci. 2018. PMID: 29415946 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,102 results

Search Page

Filters